NYSE:ABBVBiotechs
How the Bretisilocin Acquisition Could Shift AbbVie’s 2025 Valuation Debate
Thinking about whether you should buy, hold, or cash out of AbbVie? You’re not alone. This stock has been anything but quiet lately, with its price closing at $218.34. Over just the last week, AbbVie jumped 4.1%, stacking on top of a solid 5.6% gain over the last month. Stretch that timeline out and AbbVie's numbers become even more impressive, with a 21.7% return year-to-date and nearly 200% over five years. These are the kinds of figures that tend to turn heads.
What’s driving this surge in...